Hoogwerf, Byron J.

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

Ismail-Beigi, F., Craven, T., Banerji, M. A., Basile, J., Calles, J., Cohen, R. M., Cuddihy, R., Cushman, W. C., Genuth, S., Grimm, R. H., et al. (2010) · The Lancet

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 1,428

Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications

Franz, M. J., Bantle, J. P., Beebe, C. A., Brunzell, J. D., Chiasson, J.-L., Garg, A., Holzmeister, L. A., Hoogwerf, B., Mayer-Davis, E., Mooradian, A. D., et al. (2002) · Diabetes Care

Diabetes Management and ResearchDiabetes Management and Education

Cited by 1,165

The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: Retrospective epidemiological analysis of the ACCORD study

Bonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ

Diabetes Management and ResearchDiabetes Treatment and Management

Cited by 933

Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): A randomised, open-label study

Buse, J. B., Nauck, M., Forst, T., Sheu, W. H.-H., Shenouda, S. K., Heilmann, C. R., Hoogwerf, B. J., Gao, A., Boardman, M. K., Fineman, M., et al. (2013) · The Lancet

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 565

Effects of Cardiac Autonomic Dysfunction on Mortality Risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial

Pop-Busui, R., Evans, G. W., Gerstein, H. C., Fonseca, V., Fleg, J. L., Hoogwerf, B. J., Genuth, S., Grimm, R. H., Corson, M. A., Prineas, R., et al. (2010) · Diabetes Care

Heart Rate Variability and Autonomic ControlDiabetes Management and Research

Cited by 540

Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes: A Randomized, Controlled Trial

Buse, J. B., Bergenstal, R. M., Glass, L. C., Heilmann, C. R., Lewis, M. S., Kwan, A. Y. M., Hoogwerf, B. J., & Rosenstock, J. (2011) · Annals of Internal Medicine

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 506

The Lipid Accumulation Product and All‐cause Mortality in Patients at High Cardiovascular Risk: A PreCIS Database Study

Ioachimescu, A. G., Brennan, D. M., Hoar, B. M., & Hoogwerf, B. J. (2010) · Obesity

Diabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular Health

Cited by 147

Severe hypertriglyceridemia and acute pancreatitis during pregnancy: treatment with gemfibrozil.

Saadi, H. F., Kurlander, D. J., Erkins, J. M., & Hoogwerf, B. J. (1999) · Endocrine Practice

Pancreatitis Pathology and TreatmentLipid metabolism and disorders

Cited by 29

Results of a 24-week trial of technosphere insulin versus insulin aspart in type 2 diabetes

Hoogwerf, B. J., Pantalone, K. M., Basina, M., Jones, M. C., Grant, M., & Kendall, D. M. (2021) · Endocrine Practice

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 22

The PNPLA3 I148M variant is associated with transaminase elevations in type 2 diabetes patients treated with basal insulin peglispro

Pillai, S., Duvvuru, S., Bhatnagar, P., Foster, W., Farmen, M., Shankar, S., Harris, C., Bastyr, E., Hoogwerf, B., & Haupt, A. (2018) · The Pharmacogenomics Journal

Liver Disease Diagnosis and TreatmentPharmacogenetics and Drug Metabolism

Cited by 19